Banque Pictet & Cie’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-12,545
Closed -$318K – 652
2022
Q3
$318K Sell
12,545
-14,363
-53% -$504K ﹤0.01% 560
2022
Q2
$894K Sell
26,908
-42,708
-61% -$1.81M 0.01% 445
2022
Q1
$5.02M Sell
69,616
-90,588
-57% -$6.53M 0.04% 193
2021
Q4
$14.7M Buy
160,204
+153,155
+2,173% +$18.3M 0.11% 97
2021
Q3
$894K Buy
7,049
+695
+11% +$101K 0.01% 266
2021
Q2
$1.06M Buy
6,354
+256
+4% +$41.5K 0.01% 257
2021
Q1
$1.11M Buy
+6,098
New +$1.41M 0.01% 240

Other funds holding TDOC

Banque Pictet & Cie's TDOC Position: Q4 2022 in Review

Banque Pictet & Cie sold out of Teladoc Health (TDOC) in Q4 2022, closing a stake of 12,545 shares — an estimated $318K sold.

Banque Pictet & Cie first reported a position in TDOC in Q1 2021 and held it in 7 quarters. The position peaked at $14.7M in Q4 2021. 443 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.

  • Banque Pictet & Cie reported no remaining Teladoc Health position as of Q4 2022 after selling out during the quarter.
  • Banque Pictet & Cie sold 12,545 Teladoc Health shares in Q4 2022, an estimated $318K.
  • Banque Pictet & Cie first reported a position in Teladoc Health in Q1 2021 and held it in 7 quarters.
  • Banque Pictet & Cie's Teladoc Health position peaked at $14.7M in Q4 2021.
  • 443 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.

Based on Banque Pictet & Cie's 13F filing for Q4 2022, filed 6 Feb 2023.